ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 112 filers reported holding ACCELERON PHARMA INC in Q3 2015. The put-call ratio across all filers is 2.48 and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $34,390,000 | -20.6% | 1,347,553 | +12.6% | 0.01% | -33.3% |
| Q3 2016 | $43,321,000 | +13.0% | 1,197,052 | +6.1% | 0.01% | +12.5% |
| Q2 2016 | $38,332,000 | +35.7% | 1,128,078 | +5.4% | 0.01% | +14.3% |
| Q1 2016 | $28,240,000 | -37.1% | 1,070,110 | +16.2% | 0.01% | -30.0% |
| Q4 2015 | $44,904,000 | +83.8% | 920,917 | -6.2% | 0.01% | +66.7% |
| Q3 2015 | $24,436,000 | -17.9% | 981,351 | +4.3% | 0.01% | -14.3% |
| Q2 2015 | $29,769,000 | -5.2% | 940,872 | +14.1% | 0.01% | 0.0% |
| Q1 2015 | $31,389,000 | +1.8% | 824,732 | +4.2% | 0.01% | -12.5% |
| Q4 2014 | $30,831,000 | +186.9% | 791,349 | +122.7% | 0.01% | +166.7% |
| Q3 2014 | $10,748,000 | -12.7% | 355,415 | -1.9% | 0.00% | 0.0% |
| Q2 2014 | $12,312,000 | +78.4% | 362,428 | +81.1% | 0.00% | +50.0% |
| Q1 2014 | $6,903,000 | -0.4% | 200,099 | +14.4% | 0.00% | 0.0% |
| Q4 2013 | $6,928,000 | – | 174,954 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |